Fine Chemicals

At its December meeting, the Supervisory Board of Alzchem Group AG took an important step toward ensuring the continuity and future growth of the company: it was decided to extend the employment contracts of CEO Andreas Niedermaier and CFO Andreas Lösler, which were due to expire at the end of 2026, ahead of schedule.

The Management Board of Alzchem Group AG, with the approval of the Supervisory Board, has resolved to repurchase up to 70,000 shares of the company via the stock exchange over a period of up to 12 months, for a total purchase price of up to EUR 10 million (excluding ancillary acquisition costs).

Alzchem Group AG, a globally active specialty chemicals company, has approved a comprehensive investment program to achieve additional profitable growth and further strengthen its market position. The focus is particularly on the areas of sports, food and health. To this end, a total of around EUR 120 million is to be invested in the construction of an increasingly automated production plant for creatine and its precursors, as well as in the upstream infrastructure.

Alzchem Group AG has adopted a comprehensive investment program for further capacity expansion in creatine products.

Alzchem Group, manufacturer of the premium creatine Creapure®, and HYROX, the world’s leading fitness event series, are extending their partnership for the 2025/2026 season.